Effect of a zoster vaccine on herpes zoster-related interference with functional status and health-related quality-of-life measures in older adults

Journal of the American Geriatrics Society

Volumn 58, Issue 9, 2010, Pages 1634-1641

  Schmader, Kenneth E ^a   Johnson, Gary R ^b   Saddier, Patricia ^c   Ciarleglio, Maria ^b   Wang, William W B ^c   Zhang, Jane H ^b   Chan, Ivan S F ^c   Yeh, Shing Shing ^d   Levin, Myron J ^e   Harbecke, Ruth M ^f   Oxman, Michael N ^f  

^a GERIATRIC RESEARCH EDUCATION AND CLINICAL CENTER   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

^d STONY BROOK UNIVERSITY   (United States)

^e UNIVERSITY OF COLORADO   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

activities of daily living; aged; herpes zoster; herpes zoster vaccine

Indexed keywords

PLACEBO; VARICELLA ZOSTER VACCINE;

AGED; AGING; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; FUNCTIONAL STATUS; HERPES ZOSTER; HUMAN; MAJOR CLINICAL STUDY; MALE; PROPHYLAXIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; COMPARATIVE STUDY; COMPLICATION; DRUG EFFECTS; FOLLOW UP; MENTAL HEALTH; MIDDLE AGED; MOTOR ACTIVITY; MULTICENTER STUDY; PAIN; PAIN MEASUREMENT; PHYSIOLOGY; PROGNOSIS; PROSPECTIVE STUDY; PSYCHOLOGY; QUESTIONNAIRE; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HERPES ZOSTER; HERPES ZOSTER VACCINE; HUMANS; MALE; MENTAL HEALTH; MIDDLE AGED; MOTOR ACTIVITY; PAIN; PAIN MEASUREMENT; PROGNOSIS; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 77956310160     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2010.03021.x     Document Type: Article

References (15)

1. Hope-Simpson RE. The nature of herpes zoster: A long-term study and a new hypothesis. Proc R Soc Med 1965 58 : 9 20.
2. Schmader KE, Sloane R, Pieper C et al. The impact of acute herpes zoster pain and discomfort on functional status and quality of life in older adults. Clin J Pain 2007 23 : 490 497.
3. Chidiac C, Bruxelle J, Daures J-P et al. Characteristics of patients with herpes zoster on presentation to practitioners in France. Clin Infect Dis 2001 33 : 62 69.
4. Katz J, Cooper EM, Walther RR et al. Acute pain in herpes zoster and its impact on health-related quality of life. Clin Infect Dis 2004 39 : 342 348.
5. Oxman MN, Levin MJ, Johnson GR et al. the Shingles Prevention Study Group. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005 352 : 2271 2284.
6. Coplan PM, Schmader K, Nikas A et al. Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: Adaptation of the brief pain inventory. J Pain 2004 5 : 344 356.
7. Cleeland CS, Ryan KM. Pain assessment: Global use of the brief pain inventory. Ann Acad Med 1994 23 : 129 138.
8. Brazier J, Jones N, Kind P. Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaire. Qual Life Res 1993 2 : 169 180.
9. Gudex C, Dolan P, Kind P et al. Health state valuations from the general public using the visual analogue scale. Qual Life Res 1996 5 : 521 531.
10. Ware J Jr., Kosinski M, Keller SD. A 12-item short-form health survey: Construction of scales and preliminary tests of reliability and validity. Med Care 1996 34 : 220 233.
11. Norquist J, Nikas A, Saddier P et al Measuring aspects of daily life in patients with herpes zoster. Abstract. International Society for Quality of Life Research, 12th Annual Conference, San Francisco, CA. October, 2005.
12. Food and Drug Administration. Zostavax Package Insert [on-line]. Available at : Accessed March 21, 2010.
13. Food and Drug Administration. Zostavax (Herpes Zoster Vaccine) Questions and Answers [on-line]. Available at : Accessed March 14, 2010.
14. Simberkoff MS, Arbeit RD, Johnson GR et al. Safety of zoster vaccine in the Shingles Prevention Study: A randomized trial. Ann Intern Med 2010 152 : 545 554.
15. Murray AV, Lawless JF, Reisinger KS et al. Safety and tolerability of zoster vaccine in adults ≥60 years old. J Am Geriatr Soc 2010 58 : S21 S22.